About UsThe development of a new medicine involves the discovery of a new drug followed by a long and extensive series of clinical trials to evaluate its effectiveness and safety. These trials, which are usually designed by biopharmaceutical companies in liaison with regulators such as the United States Food and Drug Administration (FDA), are then conducted by research doctors - commonly known as investigators - from around the world. Since investigators have direct control of patient enrollment and study operations, accessing the right investigators is critical to running high quality clinical trials in the fastest possible time, and at the lowest possible cost. DrugDev.org was founded in 2009 to significantly reduce the cost of drug development by helping biopharmaceutical companies access the best investigators for their research from around the world, fast. Unlike CROs and corporate affiliates that maintain lists of investigators that they contact by fax machine, we have changed the game by applying the latest social media techniques and technologies to consistently and efficiently transforms the drug development process...
...And as each outreach effort generates more data and more referrals to specialist investigators, we have been continuously updating our database and growing our network to over 67,325 research professionals, including 62,548 research experienced and independently rated investigators. In only a short time DrugDev.org has grown from a start-up to the biggest network of independently rated research sites in the world, working with most major CROs and pharmaceutical companies to field more study opportunities to high performing sites than any other single research organization. We are providing investigators and their staff with access to more clinical study opportunities, and rewarding the best for their performance. For sponsors, we have been able to deliver an average two-month acceleration in study start-up time, generate a 62% saving in site identification and start-up costs, and ensure that over 95% of sites identified through DrugDev.org commence recruitment within 6-weeks of activation. But, most importantly, our work is developing drugs that would have been too expensive to progress without out service... helping improve the lives of patients around the world. Got more questions? You can contact us at any time at:
|